125 related articles for article (PubMed ID: 12444102)
1. Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling.
Scoles DR; Nguyen VD; Qin Y; Sun CX; Morrison H; Gutmann DH; Pulst SM
Hum Mol Genet; 2002 Dec; 11(25):3179-89. PubMed ID: 12444102
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
[TBL] [Abstract][Full Text] [Related]
3. HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line.
Scoles DR; Qin Y; Nguyen V; Gutmann DH; Pulst SM
Biochem Biophys Res Commun; 2005 Sep; 335(2):385-92. PubMed ID: 16083858
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate.
Scoles DR; Huynh DP; Chen MS; Burke SP; Gutmann DH; Pulst SM
Hum Mol Genet; 2000 Jul; 9(11):1567-74. PubMed ID: 10861283
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
[TBL] [Abstract][Full Text] [Related]
6. Effects of Nf2 missense mutations on schwannomin interactions.
Scoles DR; Chen M; Pulst SM
Biochem Biophys Res Commun; 2002 Jan; 290(1):366-74. PubMed ID: 11779178
[TBL] [Abstract][Full Text] [Related]
7. The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility.
Gutmann DH; Haipek CA; Burke SP; Sun CX; Scoles DR; Pulst SM
Hum Mol Genet; 2001 Apr; 10(8):825-34. PubMed ID: 11285248
[TBL] [Abstract][Full Text] [Related]
8. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
Kimura Y; Saya H; Nakao M
Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
[TBL] [Abstract][Full Text] [Related]
9. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G
Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
Huynh DP; Pulst SM
Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
[TBL] [Abstract][Full Text] [Related]
12. Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology.
Fernandez-Valle C; Tang Y; Ricard J; Rodenas-Ruano A; Taylor A; Hackler E; Biggerstaff J; Iacovelli J
Nat Genet; 2002 Aug; 31(4):354-62. PubMed ID: 12118253
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines.
Rayanade RJ; Ndubuisi MI; Etlinger JD; Sehgal PB
J Immunol; 1998 Jul; 161(1):325-34. PubMed ID: 9647240
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.
Thaxton C; Lopera J; Bott M; Baldwin ME; Kalidas P; Fernandez-Valle C
Mol Cell Neurosci; 2007 Feb; 34(2):231-42. PubMed ID: 17175165
[TBL] [Abstract][Full Text] [Related]
16. Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways.
Thaxton C; Lopera J; Bott M; Fernandez-Valle C
Oncogene; 2008 Apr; 27(19):2705-15. PubMed ID: 17998937
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
Cacalano NA; Sanden D; Johnston JA
Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
